Google
XOMA — XOMA CORP (Healthcare >> Biotechnology)
XOMA FAQ
What is XOMA's P/E ratio?
XOMA CORP (XOMA) currently trades at a P/E ratio of 16.60.
What is XOMA's ROE?
XOMA CORP reports a Return on Equity (ROE) of 27.91%.
What is XOMA's dividend yield?
XOMA CORP offers a dividend yield of 0.00%.
What is XOMA's Deepscope Quality Score?
Deepscope rates XOMA's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy XOMA?
Deepscope's AI Timing Score for XOMA is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does XOMA belong to?
XOMA CORP is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 42.09
Price
-0.31
(-0.73%)
Day Change
|
|
|---|
XOMA, the overall quality is not quite good ( Quality = 54) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not quite good , and ability to make profit is ok , ...
| Quality Factors |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 91 |
| Magic Formula Rank by ROA |
648
|
| Magic Formula Rank by ROE |
648
|
| Magic Formula Rank by ROIC |
661
|
| Price | 42.09 |
| PBV / Sector |
4.63 / 4.63
|
| Earning Per Share | 2.54 |
| PE / Sector |
16.60 / 17.43
|
| PEG or PE/Growth / Sector |
-0.28 / 0.53
|
| Average 1M Daily Value |
4.25 M
GREAT
|
| Average 1W Daily Value |
3.70 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
50% |
| Ability to Make Profit |
|
64% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:09:19 |
| Symbol | XOMA |
| Name | XOMA CORP |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 12.54 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 522.96 / 8,857.28 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 2200 Powell Street, EmeryVille, CA, United States, 94608
Phone: 510 204 7200
Website: https://www.xoma.com
Sector: Healthcare >> Biotechnology
Description: XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
